United States
Germany
Japan
United Kingdom
China
CNY 3,540.00
5周
Assay Kits
Anti-BRAF mouse monoclonal antibody, clone OTI4C11 (formerly 4C11)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human, Dog, Mouse, Rat |
Mouse Monoclonal YAP1 Antibody (1A12)
| Applications | ELISA, FC, ICC/IF, IHC, IP, WB |
| Reactivities | Human |
TA336916 is a replacement of AM06727PU-N.
Anti-BRAF mouse monoclonal antibody, clone OTI4C11 (formerly 4C11)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human, Dog, Mouse, Rat |
CD62E (SELE) (+CD62P) mouse monoclonal antibody, clone 1.2B6, Purified
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human, Porcine |
Laminin alpha 5 (LAMA5) mouse monoclonal antibody, clone 4B12, Purified
| Applications | ELISA, IF, IHC, IP |
| Reactivities | Human |
Factor H (CFH) mouse monoclonal antibody, clone OX-24, Purified
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
CD44 mouse monoclonal antibody, clone B-F24, Azide Free
| Applications | ELISA, FC, FN, IP |
| Reactivities | Human |
Laminin alpha 4 (LAMA4) mouse monoclonal antibody, clone 3H2, Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
Laminin alpha 4 (LAMA4) mouse monoclonal antibody, clone 6C3, Purified
| Applications | ELISA, IP, WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Category
Target Symbol
Reactivities
Knockout (KO) Validation
Clonalities
Assay Types
Brands
Pathways
- Natural killer cell mediated cytotoxicity (11)
- Cytokine-cytokine receptor interaction (9)
- Jak-STAT signaling pathway (8)
- Toll-like receptor signaling pathway (8)
- Focal adhesion (7)
- Pathways in cancer (7)
- Cytosolic DNA-sensing pathway (6)
- RIG-I-like receptor signaling pathway (6)
- ECM-receptor interaction (5)
- Regulation of autophagy (5)
- Chemokine signaling pathway (4)
- Small cell lung cancer (4)
- Acute myeloid leukemia (3)
- Antigen processing and presentation (3)
- Autoimmune thyroid disease (3)
- Bladder cancer (3)
- Chronic myeloid leukemia (3)
- Colorectal cancer (3)
- Endometrial cancer (3)
- ErbB signaling pathway (3)
- Glioma (3)
- Insulin signaling pathway (3)
- Long-term depression (3)
- Long-term potentiation (3)
- MAPK signaling pathway (3)
- Melanoma (3)
- Neurotrophin signaling pathway (3)
- Non-small cell lung cancer (3)
- Pancreatic cancer (3)
- Progesterone-mediated oocyte maturation (3)
- Prostate cancer (3)
- Regulation of actin cytoskeleton (3)
- Renal cell carcinoma (3)
- Thyroid cancer (3)
- Vascular smooth muscle contraction (3)
- mTOR signaling pathway (3)
- Allograft rejection (2)
- Complement and coagulation cascades (2)
- Graft-versus-host disease (2)
- Proteasome (2)
- Systemic lupus erythematosus (2)
- T cell receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Type I diabetes mellitus (2)
- Cell adhesion molecules (CAMs) (1)
- Endocytosis (1)
- Gap junction (1)
- Hematopoietic cell lineage (1)
- Pathogenic Escherichia coli infection (1)
